CSL Plasma to install Haemonetics plasma collection systems across U.S. centers
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
What happened
Haemonetics shares surged more than 15% after the medical technology company announced that CSL Plasma plans to install its plasma collection systems at all of its U.S. centers. CSL Plasma expects the rollout of Haemonetics' NexSys PCS plasma collection devices, along with related disposable kits, to be completed by the end of 2027. This expansion follows a non-exclusive supply agreement signed between the two companies in August 2026.
From ibtimes.com.au
Why it matters
The agreement represents a major contract for Haemonetics from CSL Plasma, which operates one of the world's largest networks of plasma donation centers. CSL Plasma collects plasma used to create therapies for immune deficiencies and bleeding disorders. The transition involves deploying Haemonetics' specific plasma collection technology across the entire U.S. network.
From ibtimes.com.au
Who's involved
- HaemoneticsMedical technology company supplying plasma collection systems
- CSL PlasmaNetwork of plasma collection centers planning system installation
- CSL LimitedAustralian biotechnology company that owns CSL Plasma
How it developed
Newest first. Tap a step to see who reported it.CSL and Haemonetics formalized a supply agreement for plasma collection devices.1 source
Haemonetics shares traded on NYSE; CSL Plasma plans system installation.1 source
Keep exploring
The entities involved
-
Haemonetics
company based in Braintree, Massachusetts, USA
Nothing else this week.
-
CSL Plasma
Network of plasma collection centers operated by CSL Behring
Nothing else this week.